Chemotherapy for advanced gastric cancer: across the years for a standard of care

Author： Scartozzi Mario Galizia Eva Verdecchia Lorena Berardi Rossana Antognoli Stefania Chiorrini Silvia Cascinu Stefano

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.8, Iss.6, 2007-04, pp. : 797-808

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Available options in chemotherapy for advanced gastric cancer: the current developments in Japan

By Koizumi Wasaburo

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 2, 2005-02 ,pp. : 225-231

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy for advanced gastric or gastroesophageal cancer: defining the contributions of docetaxel

By Ajani Jaffer A

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1627-1631

Informa Healthcare

Access to resources Recommend Favorite

Capecitabine in advanced gastric cancer

By Okines Alicia Chau Ian Cunningham David

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2851-2861

Informa Healthcare

Access to resources Recommend Favorite

Conjoint Analysis of a New Chemotherapy: Willingness to Pay and Preference for the Features of Raltitrexed versus Standard Therapy in Advanced Colorectal Cancer

By Aristides M.

PharmacoEconomics, Vol. 20, Iss. 11, 2002-01 ,pp. : 775-784

Adis International

Access to resources Recommend Favorite

Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer

By Yoo Changhoon Ryu Min-Hee Na Young-Soon Ryoo Baek-Yeol Lee Chae-Won Maeng Jeheon Kim Se-Yeon Koo Dong Park Inkeun Kang Yoon-Koo

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 271-278

Springer Publishing Company

Access to resources Recommend Favorite